Dr. Reddy’s to Rename Semaglutide Drug Following Court Concerns
Brand Name Change Underway
New Delhi – Dr. Reddy’s Laboratories informed the Delhi High Court on Friday that it intends to change the brand name of its semaglutide drug from ‘Olymviq’ to ‘Olymra’. This decision follows a judge’s...
brand name change
diabetes
dr. reddy's laboratories
drug approval
generic drugs
glp-1receptoragonist
india
legal dispute
novo nordisk
olymra
olymviq
ozempic
pharmaceuticals
semaglutide
type 2 diabetes
